StockTipsArenaBeta

BUY HDFC Life Insurance Company Limited — Emkay Global

BUYHDFC Life Insurance Company Limited
HDFC Life Insurance Company share price target & all analyst calls

byEmkay GlobalHorizon: NA (inferred 1 year)16 Oct 2025via Institutional / Brokerage Research

Entry₹742.85Inferred
Target₹850
Total upside +14.42% (call closed)
Stop lossNot given
At expiry₹55316 Oct 2026, 3:30 pm
Expired-25.56%auction close
Follow Emkay Global for new calls(64% target hit, 375 closed calls)Get alertsWatch HDFCLIFE for new buy/sell callsGet alertsSee 28 active Long-term calls on HDFCLIFESee 209 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 16 Oct 2026
13 supporting7 neutral1 opposing
Supports the BUY call (13)

Ujjivan Small Finance Bank approves preferential issue worth ₹409 crore to IFC, three other insurers

NewsCnbc-Tv18·16 Oct · today

(opens in new tab)

18 other SEBI-registered advisors have active long-term BUY calls on this stock, with 6 issued in the last 14 days

Advisor consensus · same horizon·16 Oct · today

HDFC Life reports 36 percent growth. HDFC Life stock sits 29.48 percent below its high

NewsGoogle News·9 Oct · 6d ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·9 Oct · 1w ago

HDFC Life reports INR 40 billion premiums: what it means for HDFC Life stock

NewsGoogle News·8 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (7)

HDFC Life reported its financial results for the quarter and half-year ended September 30, 2026, and received board approval to raise up to ₹500 crore through non-convertible debentures.

BSE · Board Meeting·15 Oct · today

(opens in new tab)

HDFC Life reported its unaudited financial results for the quarter and half-year ended September 30, 2026, and received board approval to raise up to 500 crore via non-convertible debentures.

NSE · Outcome of Board Meeting·15 Oct · today

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on HDFC Life Insurance Company

All analyst calls on HDFC Life Insurance Company

More from Emkay Global

Every call and its outcome